牙周炎与糖尿病的双向联系:机制与证据
本文综述糖尿病与牙周炎的双向关系:糖尿病控制不佳增加牙周炎风险、严重度与进展,机制涉及口腔微生物失调、炎症与免疫失调及骨代谢改变;牙周炎与血糖控制不良相关,随机对照试验显示牙周治疗使HbA1c降低约0.43%。综述强调将牙周护理整合入糖尿病管理。
要点
- 糖尿病控制不佳显著增加牙周炎风险、严重度和进展。
- 牙周治疗可使糖尿病患者HbA1c降低约0.43%。
- 牙周炎与口腔菌群失调可能促进全身炎症和胰岛素抵抗。
核心结论
- 糖尿病与牙周炎存在复杂的双向关系,二者互相加重。
- 牙周炎与血糖控制不良相关,牙周治疗可降低HbA1c约0.43%。
- 将牙周护理整合入糖尿病管理具有价值。
研究设计与样本
- 本文为综述,汇总机制研究与临床研究证据。
- 证据包括临床研究、纵向荟萃分析和随机对照试验。
主要发现
- 糖尿病控制不佳显著增加牙周炎风险、严重度和进展。
- 高血糖与口腔微生物失调相关,并伴随炎症增加、上皮屏障功能障碍、中性粒细胞和巨噬细胞功能受损、T细胞谱改变及细胞因子失衡。
- 糖尿病改变骨代谢,促进破骨细胞生成并减少修复性骨再生。
- 牙周炎与血糖控制不良强相关,随机对照试验显示牙周治疗使HbA1c降低约0.43%。
- 牙周炎和口腔临床前菌群失调可能促进糖尿病发生,但因果关系尚不确定。
关键数值与推荐
- 随机对照试验显示牙周治疗使HbA1c降低约0.43%。
- 糖尿病控制不佳显著增加牙周炎风险、严重度和进展。
临床怎么用
- 应将牙周护理整合入糖尿病管理。
- 牙周治疗可能改善糖尿病患者的血糖控制。
- 需关注牙周治疗对全身结局影响的治疗异质性。
局限性
- 牙周炎与口腔菌群失调促进糖尿病发生的因果关系尚不确定。
- 评估牙周治疗对全身结局影响的试验显示显著治疗异质性,需未来研究阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetes mellitus (DM) and periodontitis share a complex, bidirectional relationship, with each condition exacerbating the other. Diabetes, particularly when poorly controlled, significantly increases the risk, severity, and progression of periodontitis. The biological mechanisms involved are complex and numerous. Hyperglycemia in diabetes is linked to oral microbial dysbiosis, which is in turn associated with increased inflammation, epithelial barrier dysfunction, impaired neutrophil and macrophage function, altered T-cell profiles, and cytokine imbalance, collectively fostering chronic inflammation and immune dysregulation. Moreover, diabetes alters bone metabolism, promoting osteoclastogenesis and reducing reparative bone regeneration by limiting coupled bone formation through an effect on growth factor production, mesenchymal stems cells, and osteoblasts. Conversely, periodontitis is strongly linked to poor glycemic control. Clinical studies and longitudinal meta-analyses report consistent positive associations, while randomized controlled trials show that periodontal therapy reduces HbA1c by ~0.43%. Emerging evidence suggests that periodontitis and oral preclinical dysbiosis contribute to diabetogenesis, although causality remains uncertain. Periodontitis may drive metabolic dysfunction through several biological mechanisms. The dysbiotic oral microbiome and subsequent periodontitis may promote systemic inflammation and subsequent insulin resistance and glucose intolerance. Moreover, oral dysbiosis may deplete nitrate-reducing taxa and impair nitric oxide pathways, which has relevance to both periodontal and cardiometabolic health. Accordingly, periodontal treatment in diabetic populations has shown potential health care savings. Nevertheless, trials assessing the influence of periodontitis treatment on systemic outcomes consistently show significant treatment heterogeneity, which requires explication in future studies. This review underscores the systemic implications of periodontitis in diabetes and highlights the value of integrating periodontal care into diabetes management. A better understanding of the shared pathophysiology between these diseases supports interdisciplinary approaches and points toward novel preventive and therapeutic strategies targeting inflammation, microbial balance, and host response modulation to jointly benefit periodontal and cardiometabolic health.
引用
- Graves DT, Levine MA, Aldosary S, et al. Understanding the Periodontitis-Diabetes Linkage: Mechanisms and Evidence. J Dent Res. 2025. PMID: 41292096. doi:10.1177/00220345251388340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。